Olof Ulf Stefan Björklund
Directeur/Bestuurslid bij ProNoxis AB
Actieve functies van Olof Ulf Stefan Björklund
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Directeur/Bestuurslid | - | - |
| Swedish Pharmaceutical Society | Corporate Officer/Principal | - | - |
Loopbaan van Olof Ulf Stefan Björklund
Eerdere bekende functies van Olof Ulf Stefan Björklund
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Directeur/Bestuurslid | 01-01-2016 | - |
| OxyPharma AB | President | - | - |
| Pharmacia AB | Corporate Officer/Principal | - | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Algemeen Directeur | - | 20-10-2014 |
| Operationeel Directeur | - | - |
Opleiding van Olof Ulf Stefan Björklund
| University of Uppsala | Graduate Degree |
Statistieken
Internationaal
| Zweden | 8 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
| OxyPharma AB | |
| Swedish Pharmaceutical Society | |
| Pharmacia AB | Health Technology |
